Literature DB >> 7985198

Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled or carpet viper (Echis 'pyramidum'-complex): failure of antivenom treatment.

A Gillissen1, R D Theakston, J Barth, B May, M Krieg, D A Warrell.   

Abstract

A young man in Germany was bitten by a large captive saw-scaled viper (Echis 'pyramidum'-complex) of Tunisian origin. During the first few hours after the bite he developed evidence of disseminated intravascular coagulation and fibrinolysis, and bled spontaneously. Despite being given a total of 310 ml of three different Echis-specific antivenoms (together with large amounts of fresh frozen plasma and concentrated clotting factors), venom antigenaemia (measured by enzyme immunoassay) and coagulopathy persisted for more than 10 days, and he developed a haemolytic anaemia and mild renal dysfunction. Transient bilateral ptosis was attributed to envenoming. The venom of the snake responsible for the bite was immunologically distinct from that of Nigerian E. ocellatus and was clearly not neutralised by the three monospecific antivenoms which had been administered. This case is another illustration of the geographical variation in snake venoms and the need for pooling venoms from snakes from different parts of the geographical range in the preparation of antivenoms. Envenoming by North African Echis species may not be reversible by available antivenoms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985198     DOI: 10.1016/0041-0101(94)90372-7

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  13 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Persistent coagulopathy in snake bite.

Authors:  Alka Khadwal; Bhavneet Bharti; Banani Poddar; Srikant Basu; Virender Singh Virdi; Veena Parmar
Journal:  Indian J Pediatr       Date:  2003-05       Impact factor: 1.967

Review 3.  Treatment of bites by adders and exotic venomous snakes.

Authors:  David A Warrell
Journal:  BMJ       Date:  2005-11-26

4.  Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution.

Authors:  Axel Barlow; Catharine E Pook; Robert A Harrison; Wolfgang Wüster
Journal:  Proc Biol Sci       Date:  2009-04-01       Impact factor: 5.349

Review 5.  Diagnosis of snakebite and the importance of immunological tests in venom research.

Authors:  R David G Theakston; Gavin D Laing
Journal:  Toxins (Basel)       Date:  2014-05-23       Impact factor: 4.546

6.  Detection of venom after antivenom is not associated with persistent coagulopathy in a prospective cohort of Russell's viper (Daboia russelii) envenomings.

Authors:  Kalana Maduwage; Margaret A O'Leary; Fiona E Scorgie; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harindra Karunathilake; Lisa F Lincz; Christeine A Gnanathasan; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

7.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

8.  Comparative proteomics of geographically distinct saw-scaled viper (Echis carinatus) venoms from India.

Authors:  Siddharth Bhatia; Karthikeyan Vasudevan
Journal:  Toxicon X       Date:  2020-06-23

9.  Impact of Naja nigricollis Venom on the Production of Methaemoglobin.

Authors:  Harry F Williams; Paul Hayter; Divyashree Ravishankar; Anthony Baines; Harry J Layfield; Lorraine Croucher; Catherine Wark; Andrew B Bicknell; Steven Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2018-12-15       Impact factor: 4.546

10.  Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts.

Authors:  Nicholas R Casewell; Robert A Harrison; Wolfgang Wüster; Simon C Wagstaff
Journal:  BMC Genomics       Date:  2009-11-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.